Prevalence of hypogonadism among men with weight loss related to human immunodeficiency virus infection who were receiving highly active antiretroviral therapy

Clinical Infectious Diseases

Volumn 31, Issue 5, 2000, Pages 1240-1244

  Rietschel, Petra ^a   Corcoran, Colleen ^a   Stanley, Takara ^a   Basgoz, Nesli ^a   Klibanski, Anne ^a   Grinspoon, Steven ^a  

^a MASSACHUSETTS GENERAL HOSPITAL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIRETROVIRUS AGENT; CD4 ANTIGEN; TESTOSTERONE;

ADULT; ANDROGEN THERAPY; ARTICLE; BODY WEIGHT DISORDER; CONTROLLED STUDY; DISEASE ASSOCIATION; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; HYPOGONADISM; LEAN BODY WEIGHT; LYMPHOCYTE COUNT; MAJOR CLINICAL STUDY; MALE; PREVALENCE; PRIORITY JOURNAL; QUALITY OF LIFE; TESTOSTERONE BLOOD LEVEL; WASTING SYNDROME; WEIGHT REDUCTION;

ADULT; ANTI-HIV AGENTS; CASE-CONTROL STUDIES; DATA INTERPRETATION, STATISTICAL; HIV INFECTIONS; HIV PROTEASE INHIBITORS; HUMANS; HYPOGONADISM; MALE; MASSACHUSETTS; PREVALENCE; REVERSE TRANSCRIPTASE INHIBITORS; SEX HORMONE-BINDING GLOBULIN; TESTOSTERONE; WASTING SYNDROME; WEIGHT LOSS;

EID: 0034456965     PISSN: 10584838     EISSN: None     Source Type: Journal    
DOI: 10.1086/317457     Document Type: Article

References (26)

1. Endocrine disorders in men infected with human immunodeficiency virus
2. Endocrine function in 98 HIV-infected patients: A prospective study
3. Changes in systemic gonadal and adrenal steroids in asymptomatic human immunodeficiency virus-infected men: Relationship with CD4 cell counts
4. Loss of lean body mass and muscle mass correlates with androgen levels in hypogonadal men with acquired immunodeficiency syndrome and wasting
5. Serum hormones in men with human immunodeficiency virus-associated wasting
6. Effects of testosterone replacement with a nongenital, transdermal system, androderm, in human immunodeficiency virus-infected men with low testosterone levels
7. Effects of androgen administration in men with AIDS wasting: A randomized, placebo-controlled, trial
8. Sustained anabolic effects of long-term androgen administration in men with AIDS wasting
9. A trial of testosterone therapy for HIV-associated weight loss
10. The use of a transscrotal testosterone delivery system in the treatment of patients with weight loss related to human immunodeficiency virus
11. Hypogonadism and wasting in the era of HAART in HIV-infected patients
12. 1983 height and weight tables
13. Case records of the Massachusetts General Hospital. Weekly clinicopathological exercises: Normal reference laboratory values
14. Fasting hyperinsulinemia in HIV-infected men: Relationship to body composition, gonadal function and protease-inhibitor use
15. Effects of hypogonadism and testosterone administration on depression indices in HIV-infected men
16. Changes in the hypothalamic-pituitary-gonadal axis in human immunodeficiency virus-infected homosexual men
17. Amplitude suppression of the pulsatile mode of immunoradiometric luteinizing hormone release in fasting-induced hypoandrogenemia in normal men
18. Slowing of pulsatile luteinizing hormone secretion in men after forty-eight hours fasting
19. Transient hypogonadotropic hypogonadism caused by critical illness
20. Gonadal dysfunction in systemic disorders
21. Effect of megestrol acetate therapy on body composition and circulating testosterone concentration in patients with AIDS
22. Pathology of the pituitary gland in patients with the acquired immune deficiency syndrome (AIDS)
23. Illness stage, concurrent medications, and other correlates of low testosterone in men with HIV illness
24. Alterations in the concentrations and binding properties of sex steroid binding protein and corticosteroid-binding globulin in HIV+ patients
25. The analog Free testosterone assays: Are the results in men clinically useful?
26. Effects of testosterone and progressive resistance training in eugonadal men with AIDS wasting: A randomized, controlled trial